Kiniksa Pharmaceuticals International, plc
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
Country
United Kingdom
Business Address
105 PICCADILLY, SECOND FLOOR, LONDON, , W1J 7NJ
Mailing Address
105 PICCADILLY, SECOND FLOOR, LONDON, , W1J 7NJ
Phone
7814319100
Fiscal Year End
1231
EIN
981795578
Financial Overview
FY2025
$763.63M
Total Assets
$196.03M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
Insider Trading
STRONG SELL
4 insiders
16 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.